BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6953563)

  • 1. Chromosomal, morphological and clinical correlations in blastic crisis of chronic myeloid leukaemia: a study of 69 cases.
    Alimena G; Dallapiccola B; Gastaldi R; Mandelli F; Brandt L; Mitelman F; Nilsson PG
    Scand J Haematol; 1982 Feb; 28(2):103-17. PubMed ID: 6953563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of chromosomal findings in the blast phase of Ph1-positive chronic myeloid leukaemia (CML).
    Oláh E; Rák K
    Int J Cancer; 1981 Mar; 27(3):287-95. PubMed ID: 6945294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome abnormalities in chronic myeloid leukemia in children.
    Puchkova GP; Prigogina EL; Fleischmann EW; Drosdova TS; Mayakova SA; Peterson IS
    Hum Genet; 1983; 64(3):257-62. PubMed ID: 6576982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations between the clinical course, characteristics of blast cells, and karyotype patterns in chronic myeloid leukemia.
    Fleischman EW; Prigogina EL; Volkova MA; Frenkel MA; Zakhartchenko NA; Konstantinova LN; Puchkova GP; Balakirev SA
    Hum Genet; 1981; 58(3):285-93. PubMed ID: 6948765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome changes and splenectomy in Ph1-positive chronic myeloid leukemia. I. Predictive parameters in the blastic phase.
    Sadamori N; Sandberg AA
    Cancer; 1984 Dec; 54(11):2456-9. PubMed ID: 6594187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth pattern and SCE incidence in Ph1-positive cells of CML.
    Abe S; Kakati S; Sandberg AA
    Cytobios; 1980; 28(111-112):137-49. PubMed ID: 6938334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomes and causation of human cancer and leukemia: XXXIX. Usual and unusual findings in Ph1-positive CML.
    Kohno SI; Sandberg AA
    Cancer; 1980 Nov; 46(10):2227-37. PubMed ID: 6932994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomes and causation of human cancer and leukemia. IL. Therapeutic and prognostic value of chromosomal findings during acute phase in Ph1-positive chronic myeloid leukemia.
    Sadamori N; Gomez GA; Sandberg AA
    Hematol Oncol; 1983; 1(1):77-83. PubMed ID: 6588019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variant Ph1 translocations in CML and their incidence, including two cases with sequential lymphoid and myeloid crises.
    Oshimura M; Ohyashiki K; Terada H; Takaku F; Tonomura A
    Cancer Genet Cytogenet; 1982 Mar; 5(3):187-201. PubMed ID: 6950809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-random karyotypic evolution in chronic myeloid leukemia.
    Mitelman F; Levan G; Nilsson PG; Brandt L
    Int J Cancer; 1976 Jul; 18(1):24-30. PubMed ID: 1065618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome abnormalities and clinical and morphologic manifestations of chronic myeloid leukemia.
    Prigogina EL; Fleischman EW; Volkova MA; Frenkel MA
    Hum Genet; 1978 Mar; 41(2):143-56. PubMed ID: 273570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translocations (4p+; 6q-) and (12q-; Xp+) in blastic phase of a Ph1-positive chronic myeloid leukemia.
    Suciu S; Marinca E; Bornuz F; Crisan M; Petrov L; Rădulescu E
    Blut; 1984 Oct; 49(4):325-30. PubMed ID: 6593103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of chromosomal findings in Ph1-positive chronic myelocytic leukemia.
    Sakurai M; Hayata I; Sandberg AA
    Cancer Res; 1976 Feb; 36(2 Pt 1):313-8. PubMed ID: 1063061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible cytogenetic distinction between lymphoid and myeloid blast crisis in chronic granulocytic leukemia.
    Diez-Martin JL; Dewald GW; Pierre RV
    Am J Hematol; 1988 Mar; 27(3):194-203. PubMed ID: 3279762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transformation of chronic myelogenous leukemia: clinical, morphologic, and cytogenetic features.
    Muehleck SD; McKenna RW; Arthur DC; Parkin JL; Brunning RD
    Am J Clin Pathol; 1984 Jul; 82(1):1-14. PubMed ID: 6588747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomes and causation of human cancer and leukemia. XXIX. Further studies on karyotypic progression in CML.
    Sonta S; Sandberg AA
    Cancer; 1978 Jan; 41(1):153-63. PubMed ID: 272225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The chromosomes and causation of human cancer and leukemia: XXXVIII. Cytogenetic experience in Ph1-negative chronic myelocytic leukemia (CML).
    Kohno S; Abe S; Sandberg AA
    Am J Hematol; 1979; 7(3):281-91. PubMed ID: 296877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic and prognostic value of initial chromosomal findings at the blastic phase of Ph1-positive chronic myeloid leukemia.
    Sadamori N; Gomez GA; Sandberg AA
    Blood; 1983 May; 61(5):935-9. PubMed ID: 6572536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome banding studies in Philadelphia chromosome positive myeloid leukaemia.
    Lawler SD; O'Malley F; Lobb DS
    Scand J Haematol; 1976 Jul; 17(1):17-28. PubMed ID: 1066809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordant patterns of chromosome changes and myeloblast proliferation during the terminal phase of chronic myeloid leukemia.
    Gall JA; Boggs DR; Chervenick PA; Pan S; Fleming RB
    Blood; 1976 Mar; 47(3):347-53. PubMed ID: 1062222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.